Role of plasma concentration monitoring in the evaluation of response to antiarrhythmic drugs
- 19 October 1988
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (12), H9-H17
- https://doi.org/10.1016/0002-9149(88)90335-9
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.Circulation, 1988
- Identifying Patients Who Might Benefit from Free Phenytoin MonitoringTherapeutic Drug Monitoring, 1987
- Specific High Performance Liquid Chromatographic Determination of Quinidine in Serum, Blood, and UrineTherapeutic Drug Monitoring, 1987
- Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.Journal of Clinical Investigation, 1984
- Plasma level monitoring of antiarrhythmic drugsThe American Journal of Cardiology, 1983
- Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamideThe American Journal of Cardiology, 1980
- Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.Circulation, 1979
- Divergence in pharmacokinetic parameters of quinidine obtained by specific and nonspecific assay methodsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Protein Binding of Diphenylhydantoin and Desmethylimipramine in Plasma from Patients with Poor Renal FunctionNew England Journal of Medicine, 1971
- Blood Quinidine Concentrations as a Guide in the Treatment of Cardiac ArrhythmiasCirculation, 1950